Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Keswani Sanjay Chandru received 3,914 Neurocrine Biosciences, Inc. shares as an award (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Keswani Sanjay Chandru (Chief Medical Officer) received 3,914 Neurocrine Biosciences, Inc. shares as an award, leaving 3,281 shares. Filed Sep 15, 2026 (Form 4).
- Awarded
- 3,914 shares
- Holding after
- 3,281 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 3,914 | 5,393 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 2,112 | US$156.22 | 3,281 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Keswani Sanjay Chandru
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Keswani Sanjay Chandru · Jun 4, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026